Key result
Hypertension link to high FIB-4 index in hepatic steatosis remains unquantified.
Why the study?
Is hypertension associated with a high FIB-4 index and progression to a high FIB-4 index in patients with hepatic steatosis?
Cohort
Is hypertension associated with a high FIB-4 index and progression to a high FIB-4 index in patients with hepatic steatosis?
Introduction Steatotic liver disease is increasingly prevalent, and individuals with steatotic liver disease and high Fibrosis-4 (FIB-4) index levels are at a higher risk of liver-related or non-liver-related mortality. Therefore, we investigated the factors associated with a high FIB-4 index (a surrogate marker of liver fibrosis) in patients with hepatic steatosis and progression to a high FIB-4 index with hepatic steatosis during 5 years of follow-up after undergoing health checkups.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2026) conducted a cohort in Hepatic steatosis. Hypertension was evaluated on High FIB-4 index and progression to a high FIB-4 index. The provided abstract does not report quantitative results regarding the association between hypertension and a high FIB-4 index in individuals with hepatic steatosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: